T3+ and T4 Rectal Cancer Patients Seem to Benefit From the Addition of Oxaliplatin to the Neoadjuvant Chemoradiation Regimen - Concepedia

Concepedia

Publication | Closed Access

T3+ and T4 Rectal Cancer Patients Seem to Benefit From the Addition of Oxaliplatin to the Neoadjuvant Chemoradiation Regimen

26

Citations

44

References

2011

Year

Ingrid S. Martijnse, R. Dudink, Miranda Kusters, T.A. Vermeer, Nicholas P. West, Grard A. P. Nieuwenhuijzen, Ineke van Lijnschoten, Hendrik Martijn, Geert‐Jan Creemers, V.E.P.P. Lemmens,

Annals of Surgical Oncology

Radiation TherapyNeoadjuvant Chemoradiation RegimenMedicineGastrointestinal OncologySurgeryCancer TreatmentOncologyRadiation OncologyCancer ResearchRadiologyHealth Sciences

References

	Year	Citations

Page 1

Page 1